Table 3.
Symptomatic status of participants positive for SARS-CoV-2 antibodies against N-protein, and receptor-binding domain (RBD).
| SARS-CoV-2 Antibodies | Asymptomatic | Symptomatic | |||||
|---|---|---|---|---|---|---|---|
| Total n | n (%) | Median Age in Years (Range) |
Male, n (%) |
n (%) | Median Age in Years (Range) | Male n (%) |
|
| Anti-N positive | 79 | 39 (49.4) | 38 (20–70) | 18 (46.2) | 40 (50.6) | 24.5 (18–64) | 13 (32.5) |
| Anti-S RBD positive | 79 | 35 (44.3) | 37 (19–70) | 17 (48.6) | 44 (55.7) | 24 (18–64) | 14 (31.8) |
| Anti-N & anti-S RBD positive | 70 | 32 (45.7) | 38 (20–70) | 16 (50.0) | 38 (54.3) | 24.5 (18–64) | 13 (34.2) |